The antibody clone H6 was produced by immunizing mouse with Killer toxin (KT) produced by the yeast Pichia anomala. It can be used for detection of Yeast KT in DB and IF staining.
Figure 1 Kaplan-Meier survival curve of normal BALB/c with infection challenge treated with 50 μg KP, SP, or fluconazole, or untreated.
BALB/c (eight per group) were infected intravenously on day 0 with 107 C. albicans cells (strain SA-40; predetermined to correspond to five LD50's) and then intraperitoneally injected with 50 μg of KP (VS-0623-WK31), SP, or fluconazole in saline at 1, 24, and 48 h, after the infectious challenge.
Figure 2 Candidacidal activity of KP (VS-0623-WK31) in vivo.
All rats (five per group) were challenged intravaginally with 107 C. albicans cells (strain SA-40) in 0.1 ml of physiological saline on day 0 and then sampled for initial intravaginal CFU. The therapeutics (KP (VS-0623-WK31), SP, and fluconazole; 50 μg each) were administered 1, 24, and 48 h after the challenge.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for VS-0623-WK31. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.